A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects with Neovascular Age-related Macular Degeneration (AMD)
Public ClinicalTrials.gov record NCT06190093. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety and Effectiveness of ONS-5010 Compared to Lucentis® in Subjects with Neovascular Age-related Macular Degeneration; NORSE EIGHT
Study identification
- NCT ID
- NCT06190093
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Outlook Therapeutics, Inc.
- Industry
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Interventions
- bevacizumab Biological
- ranibizumab Biological
Biological
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 23, 2024
- Primary completion
- Nov 6, 2024
- Completion
- Dec 4, 2024
- Last update posted
- Feb 24, 2025
2024
United States locations
- U.S. sites
- 61
- U.S. states
- 23
- U.S. cities
- 60
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Site | Arcadia | California | 91006 | — |
| Clinical Site | Bakersfield | California | 93309 | — |
| Clinical Site | Beverly Hills | California | 90210 | — |
| Clinical Site | Huntington Beach | California | 92647 | — |
| Clinical Site | Laguna Hills | California | 92653 | — |
| Clinical Site | Long Beach | California | 90807 | — |
| Clinical Site | Modesto | California | 95356 | — |
| Clinical Site | Oakland | California | 94611 | — |
| Clinical Site | Pasadena | California | 91107 | — |
| Clinical Site | Poway | California | 92064 | — |
| Clinical Site | Sacramento | California | 95841 | — |
| Clinical Site | Colorado Springs | Colorado | 80909 | — |
| Clinical Site | Lakewood | Colorado | 80228 | — |
| Clinical Site | Waterford | Connecticut | 06385 | — |
| Clinical Site | Coral Springs | Florida | 33067 | — |
| Clinical Site | Fort Lauderdale | Florida | 33308 | — |
| Clinical Site | Jacksonville | Florida | 32216 | — |
| Clinical Site | Orlando | Florida | 32806 | — |
| Clinical Site | Stuart | Florida | 34994 | — |
| Clinical Site | Oak Forest | Illinois | 60452 | — |
| Clinical Site | Oak Park | Illinois | 03440 | — |
| Clinical Site | Carmel | Indiana | 46290 | — |
| Clinical Site | Lenexa | Kansas | 66215 | — |
| Clinical Site | Lexington | Kentucky | 40509 | — |
| Clinical Site | Hagerstown | Maryland | 21740 | — |
| Clinical Site | Edina | Minnesota | 55435 | — |
| Clinical Site | Saint Louis Park | Minnesota | 55416 | — |
| Clinical Site | Jackson | Mississippi | 39202 | — |
| Clinical Site | Teaneck | New Jersey | 07666 | — |
| Clinical Site | Albuquerque | New Mexico | 87109 | — |
| Clinical Site | Liverpool | New York | 13088 | — |
| Clinical Site | Oceanside | New York | 11572 | — |
| Clinical Site | Rochester | New York | 14620 | — |
| Clinical Site | Westbury | New York | 11590 | — |
| Clinical Site | Asheville | North Carolina | 28803 | — |
| Clinical Site | Hickory | North Carolina | 28602 | — |
| Clinical Site | Wake Forest | North Carolina | 27587 | — |
| Clinical Site | Winston-Salem | North Carolina | 27103 | — |
| Clinical Site | Edmond | Oklahoma | 73013 | — |
| Clinical Site | Charleston | South Carolina | 29414 | — |
| Clinical Site | Florence | South Carolina | 29501 | — |
| Clinical Site | Ladson | South Carolina | 29456 | — |
| Clinical Site | West Columbia | South Carolina | 29169 | — |
| Clinical Site | Rapid City | South Dakota | 57701 | — |
| Clinical Site | Germantown | Tennessee | 38138 | — |
| Clinical Site | Abilene | Texas | 79606 | — |
| Clinical Site | Arlington | Texas | 76012 | — |
| Clinical Site | Austin | Texas | 78705 | — |
| Clinical Site | Beaumont | Texas | 77707 | — |
| Clinical Site | Bellaire | Texas | 77401 | — |
| Clinical Site | Dallas | Texas | 75231 | — |
| Clinical Site | Round Rock | Texas | 78681 | — |
| Clinical Site | San Antonio | Texas | 78240 | — |
| Clinical Site | San Antonio | Texas | 78251 | — |
| Clinical Site | The Woodlands | Texas | 77384 | — |
| Clinical Site | Willow Park | Texas | 79606 | — |
| Clinical Site | Salt Lake City | Utah | 84107 | — |
| Clinical Site | Fairfax | Virginia | 22031 | — |
| Clinical Site | Lynchburg | Virginia | 24502 | — |
| Clinical Site | Bellevue | Washington | 98004 | — |
| Clinical Site | Silverdale | Washington | 98383 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06190093, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 24, 2025 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06190093 live on ClinicalTrials.gov.